Blocking Properdin Prevents Complement-Mediated Hemolytic Uremic Syndrome and Systemic Thrombophilia
Conclusions These results contrast with the detrimental effect of P inhibition observed in a murine model of C3 glomerulopathy and suggest that P contributes critically to aHUS pathogenesis. Inhibition of P in aHUS may be of therapeutic benefit.
Source: Journal of the American Society of Nephrology : JASN - Category: Urology & Nephrology Authors: Ueda, Y., Miwa, T., Gullipalli, D., Sato, S., Ito, D., Kim, H., Palmer, M., Song, W.-C. Tags: Basic Research Source Type: research
More News: Anemia | Brain | Genetics | Hemolytic Uremic Syndrome (HUS) | Liver | Neurology | Stroke | Thrombocytopenia | Urology & Nephrology